Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Wait-list Controlled Trial of Daily, Home-based Biofeedback Therapy Using Cerebri for the Prevention of Migraine Attacks in Adults With Episodic Migraine

NCT05616741 is registered in ClinicalTrials.gov with Nordic Brain Tech AS as lead sponsor.

NCT NCT05616741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05616741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Wait-list Controlled Trial of Daily, Home-based Biofeedback Therapy Using Cerebri for the Prevention of Migraine Attacks in Adults With Episodic Migraine
Lead sponsor
Nordic Brain Tech AS
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2023
Completion date
September 23, 2024
Enrollment
279 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

migraine